Prospective Randomized Study of PTC and EUS-guided Drainage of the Bile Duct
Primary Purpose
Jaundice
Status
Completed
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
biliary drainage
EUS guided biliary drainage
Sponsored by
About this trial
This is an interventional treatment trial for Jaundice focused on measuring Stenosis of biliary ways
Eligibility Criteria
Inclusion Criteria:
- age >= 18
- Karnofsky >= 50%
- biliary stenosis (malignant or benign stricture)with failure of endoscopic retrograde cholangiopancreatography
- signed informed consent
Exclusion Criteria:
- isolated biliary stenosis of right hepatic canal
- percutaneous biliary drainage < 10 days
- laparotomy < 10 days
- contra-indication to the procedure
- pregnant women
Sites / Locations
- Institut Paoli-Calmettes
- Hopital Nord
- Centre Hospitalier Princesse Grace
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Percutaneous Drainage
EUS-guided drainage
Arm Description
Percutaneous Transhepatic Biliary Drainage (PTBD)
endoscopic ultrasonography guided biliary drainage through the duodenal or the gastric wall
Outcomes
Primary Outcome Measures
Morbidity rate
Morbidity rate during 30 post-operative days
Secondary Outcome Measures
efficacy
decrease of bilirubine > 50%
feasibility
succes or not of the intervention to obtain bilairy drainage
biliary drainage duration
time between intervention and drain withdrawal
quality of life
QLQ-C30 questionnary at inclusion and at D30
Full Information
NCT ID
NCT01499537
First Posted
September 16, 2011
Last Updated
May 18, 2016
Sponsor
Institut Paoli-Calmettes
1. Study Identification
Unique Protocol Identification Number
NCT01499537
Brief Title
Prospective Randomized Study of PTC and EUS-guided Drainage of the Bile Duct
Official Title
Prospective Randomized Study of PTC and EUS-guided Drainage of the Bile Duct in Patients With Malignant or Post-operative Jaundice After Failure or Impossibility to Perform Endoscopic Retrograde Cholangiography
Study Type
Interventional
2. Study Status
Record Verification Date
February 2016
Overall Recruitment Status
Completed
Study Start Date
January 2011 (undefined)
Primary Completion Date
February 2016 (Actual)
Study Completion Date
March 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Institut Paoli-Calmettes
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
At this time, endoscopic retrograde cholangiopancreatography (ERCP) stay the gold standard method to achieve biliary drainage in case of malignant or benign stricture. When ERCP fail or if the major papilla is not suitable, percutaneous transhepatic biliary drainage (PTBD) is the most commonly used alternative, surgery having higher morbidity and mortality rates, unacceptable especially in palliative situation. Recent developments in interventional endoscopic ultrasonography (EUS) allow new endoluminal approaches to pancreatic-biliary structures, such as cysto-enterostomy or pancreatic-enterostomy. More recently were described the possibility to realize EUS-guided biliary drainage, through the duodenal or the gastric wall. Advantages of the EUS-guided approach are to be realizable even the papilla is not suitable endoscopically (duodenal stricture or post-surgical status) and to allow if necessary extra-tumoral non anatomic drainage (hepaticogastrostomy). This technique is actually an alternative to PTBD. In comparison of the PTBD, EUS-guided route seems to have less morbidity and to avoid external biliary drainage. Indeed, the morbidity rate of the percutaneous biliary drainage and the EUS-guided biliary drainage range respectively from 25 to 35% and from 0 to 23%. However, none study compare prospectively both techniques. Aims of this study are to compare the morbidity rate, feasibility and efficacy of these techniques.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Jaundice
Keywords
Stenosis of biliary ways
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
65 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Percutaneous Drainage
Arm Type
Active Comparator
Arm Description
Percutaneous Transhepatic Biliary Drainage (PTBD)
Arm Title
EUS-guided drainage
Arm Type
Experimental
Arm Description
endoscopic ultrasonography guided biliary drainage through the duodenal or the gastric wall
Intervention Type
Device
Intervention Name(s)
biliary drainage
Intervention Description
percutaneous transhepatic biliary drainage (PTBD)
Intervention Type
Device
Intervention Name(s)
EUS guided biliary drainage
Intervention Description
endoscopic ultrasonography guided biliary drainage through the duodenal or the gastric wall
Primary Outcome Measure Information:
Title
Morbidity rate
Description
Morbidity rate during 30 post-operative days
Time Frame
30 days
Secondary Outcome Measure Information:
Title
efficacy
Description
decrease of bilirubine > 50%
Time Frame
15 days
Title
feasibility
Description
succes or not of the intervention to obtain bilairy drainage
Time Frame
up to 3 days
Title
biliary drainage duration
Description
time between intervention and drain withdrawal
Time Frame
up to 1 month
Title
quality of life
Description
QLQ-C30 questionnary at inclusion and at D30
Time Frame
30 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
age >= 18
Karnofsky >= 50%
biliary stenosis (malignant or benign stricture)with failure of endoscopic retrograde cholangiopancreatography
signed informed consent
Exclusion Criteria:
isolated biliary stenosis of right hepatic canal
percutaneous biliary drainage < 10 days
laparotomy < 10 days
contra-indication to the procedure
pregnant women
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Erwan BORIES, MD
Organizational Affiliation
Institut Paoli-Calmettes
Official's Role
Principal Investigator
Facility Information:
Facility Name
Institut Paoli-Calmettes
City
Marseille
ZIP/Postal Code
13009
Country
France
Facility Name
Hopital Nord
City
Marseille
ZIP/Postal Code
13020
Country
France
Facility Name
Centre Hospitalier Princesse Grace
City
Monaco
ZIP/Postal Code
98000
Country
Monaco
12. IPD Sharing Statement
Links:
URL
http://www.institutpaolicalmettes.fr/
Description
sponsor web site
Learn more about this trial
Prospective Randomized Study of PTC and EUS-guided Drainage of the Bile Duct
We'll reach out to this number within 24 hrs